Xeris Biopharma Holdings, Inc. (NASDAQ: XERS) is making waves in the biotech sector with its compelling growth prospects and innovative therapies targeting chronic endocrine and neurological..
Savara, Inc. (NASDAQ: SVRA) is gaining significant attention in the biotech investing community, thanks to its promising pipeline and robust analyst support. This clinical-stage biopharmaceutical company,..
In the ever-evolving biotechnology sector, Geron Corporation (NASDAQ: GERN) presents a compelling investment opportunity with a potential upside of 158.99%. Headquartered in Foster City, California, this..
Cogent Biosciences, Inc. (NASDAQ: COGT) is capturing investor attention with its impressive market cap of $6.15 billion and a promising potential upside of 22.15%. As a..
For investors with an appetite for the biotech sector, Vir Biotechnology, Inc. (NASDAQ: VIR) presents a compelling opportunity. With a market capitalization of $922.4 million, this..
Butterfly Network, Inc. (NASDAQ: BFLY) is carving out a distinctive niche in the healthcare sector, specifically within the medical devices industry. Renowned for its innovative ultrasound..
OrthoPediatrics Corp. (NASDAQ: KIDS), a specialist in pediatric orthopedic medical devices, is making waves with a compelling 31.61% potential upside, as indicated by the average analyst..
Investors eyeing the healthcare sector may find CeriBell, Inc. (NASDAQ: CBLL) an intriguing opportunity. A relatively young player in the medical devices industry, CeriBell is making..
Investors keeping an eye on the biotechnology sector may want to pay close attention to Bicara Therapeutics Inc. (NASDAQ: BCAX). This clinical-stage biopharmaceutical company, based in..
Capricor Therapeutics, Inc. (NASDAQ: CAPR) is capturing the attention of biotech investors with its innovative approach to addressing unmet medical needs through cell and exosome-based therapeutics...
Replimune Group, Inc. (NASDAQ: REPL), a promising contender in the biotechnology sector, is captivating investor interest with its innovative approach to cancer treatment. Specializing in oncolytic..
ArriVent BioPharma, Inc. (NASDAQ: AVBP), a burgeoning name in the biotechnology sector, is making waves with its innovative approach to cancer treatment. This clinical-stage biopharmaceutical company,..
Avadel Pharmaceuticals plc (NASDAQ: AVDL) stands as a prominent player in the healthcare sector, specifically within the niche of specialty and generic drug manufacturing. Headquartered in..
InnovAge Holding Corp. (NASDAQ: INNV) operates within the healthcare sector, focusing on medical care facilities through its innovative Program of All-Inclusive Care for the Elderly (PACE)...
Oculis Holding AG (OCS), a Switzerland-based biotechnology firm specializing in ophthalmic diseases, is gaining attention from investors with a promising outlook. With a market capitalization of..
Tyra Biosciences, Inc. (NASDAQ: TYRA), a burgeoning player in the biotechnology sector, is drawing significant interest from investors with a potential upside of 40.29%. As a..
LENZ Therapeutics, Inc. (NASDAQ: LENZ), a promising player in the biotechnology sector, has captured the attention of investors with a potential upside of 118.37%. Operating within..
Trevi Therapeutics, Inc. (NASDAQ: TRVI), a clinical-stage biopharmaceutical company, has caught the attention of investors with its promising prospects in the biotechnology sector. Headquartered in New..
Cronos Group Inc. (NASDAQ: CRON), a notable player in the healthcare sector, operates within the highly dynamic drug manufacturing industry, specifically focusing on specialty and generic..
AnaptysBio, Inc. (NASDAQ: ANAB) stands out in the competitive biotechnology sector with its focus on delivering groundbreaking immunology therapeutics. Investors are keenly watching this San Diego-based..
